Anorectal disorders are medical disorders that occur or develop in the rectum or the anal canal. Rectal bleeding, hemorrhoids, fissures, and polyps are the common causes of anorectal disorders. The anorectal disorders can lead to excessive pain, itching and swelling around the anus and rectum and cause discomfort.             
This report contains market size and forecasts of Anorectal Disorders Treatment in Global, including the following market information:
Global Anorectal Disorders Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anorectal Disorders Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anorectal Disorders Treatment include AKORN, Novartis, Mylan, GlaxoSmithKline, Ferndale Pharma Group, F. Hoffmann-La Roche, Pfizer, Takeda Pharmaceutical Company Limited and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anorectal Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anorectal Disorders Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anorectal Disorders Treatment Market Segment Percentages, by Type, 2021 (%)
Drugs
Surgery
Others
Global Anorectal Disorders Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anorectal Disorders Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Others
Global Anorectal Disorders Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anorectal Disorders Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anorectal Disorders Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anorectal Disorders Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AKORN
Novartis
Mylan
GlaxoSmithKline
Ferndale Pharma Group
F. Hoffmann-La Roche
Pfizer
Takeda Pharmaceutical Company Limited
AstraZeneca
GlaxoSmithKline
Bristol-Myers Squibb Company
Eli Lilly and Company
Merck
Sun Pharmaceutical Industries
NATCO Pharma Limited
LUPIN
Teva Pharmaceutical Industries
Boehringer Ingelheim International
AbbVie
Allergan
Aboott
Bayer